Unlearn, an AI-enabled company, raised $50 million in Series C funding, bringing its total raise to over $130 million. The company creates digital twins of clinical trial participants using machine learning, providing researchers with insight into the participants’ health outcomes. Unlearn aims to run smaller clinical trials more quickly, and plans to invest in its engineering capabilities, research and development initiatives, data, and workforce. The company also announced a partnership with clinical-stage biotechnology company QurAlis Corporation. Other companies using digital twin technology include Mesh Bio and Twin Health. Unlearn’s CEO emphasized the value of digital twin technology and the financing will allow the company to grow and expand its capabilities.
Source link
Digital twin company Unlearn secures $50M
